Literature DB >> 8669967

CD40 ligand deficiency presenting as unresponsive neutropenia.

F J Andrews1, F Katz, A Jones, S Smith, A Finn.   

Abstract

A male child presented with recurrent respiratory infections, otitis media, and oral ulceration and was found to be neutropenic. Investigations showed hypogammaglobulinaemia with normal serum IgM and a novel deletion in the gene for CD40 ligand on his X chromosome. Intravenous gammaglobulin did not lead to resolution of his neutropenia; G-CSF was also necessary.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8669967      PMCID： PMC1511550          DOI： 10.1136/adc.74.5.458

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  Correction of neutropenia associated with dysgammaglobulinemia.

Authors:  C H Rieger; J W Moohr; R M Rothberg
Journal:  Pediatrics       Date:  1974-10       Impact factor: 7.124

2.  Bone marrow transplantation for hyper-IgM syndrome.

Authors:  A Fasth
Journal:  Immunodeficiency       Date:  1993

Review 3.  Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review.

Authors:  N Banatvala; J Davies; M Kanariou; S Strobel; R Levinsky; G Morgan
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

4.  Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor.

Authors:  W C Wang; J Cordoba; A J Infante; M E Conley
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-05

Review 5.  The CD40 antigen and its ligand.

Authors:  J Banchereau; F Bazan; D Blanchard; F Brière; J P Galizzi; C van Kooten; Y J Liu; F Rousset; S Saeland
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962
  6 in total
  7 in total

Review 1.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.

Authors:  Januario E Castro; Johanna Melo-Cardenas; Mauricio Urquiza; Juan S Barajas-Gamboa; Ramin S Pakbaz; Thomas J Kipps
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

Review 3.  Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.

Authors:  A Heinold; B Hanebeck; V Daniel; J Heyder; T H Tran; B Döhler; J Greil; F-M Müller
Journal:  Infection       Date:  2010-10-28       Impact factor: 3.553

4.  Bone marrow transplantation for CD40 ligand deficiency: a single centre experience.

Authors:  K Khawaja; A R Gennery; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

Review 5.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

6.  Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.

Authors:  Asghar Aghamohammadi; Nima Parvaneh; Nima Rezaei; Kasra Moazzami; Sara Kashef; Hassan Abolhassani; Amir Imanzadeh; Javad Mohammadi; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2009-07-03       Impact factor: 8.317

7.  Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.

Authors:  Niladri Bhusan Pati; Vikalp Vishwakarma; Sathish Kumar Selvaraj; Sabyasachi Dash; Bhaskar Saha; Neera Singh; Mrutyunjay Suar
Journal:  BMC Microbiol       Date:  2013-10-22       Impact factor: 3.605
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.